bluebird bio Revenue
Biotechnology Research • 
Somerville, Massachusetts, United States • 201-500 Employees
bluebird bio revenue & valuation
| Annual revenue | $104,000,000 |
| Revenue per employee | $267,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $332,700,000 |
| Total funding | $313,500,000 |
Key Contacts at bluebird bio
Jerry Hunter
Associate Director, Equity Administration
Wendi Mendoza
Senior Director Quality
Francesca Bastone
Director, External Stakeholder Qualified Treatment Center Engagement
Edsel Bester
Associate Director, Patient And Community Education Liaison
Nate Osborne
Director - National Accounts
Shelley Geiger
Director, Quality Treatment Center Engagement
Ken Kotz
Director
Sharon Schall
Senior Director Qtc Engagement, Florida
Emily Pereira
Senior Director, Clinical Data Management
Renato Luis
Sr Director Of Financial Planning And Analysis
Company overview
| Headquarters | 455 Grand Union Blvd, Somerville, Massachusetts 02145, US |
| Phone number | +13394999300 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Gene Therapy, Sickle Cell Disease, Gene Addition, Beta-Thalassemia, Cerebral Adrenoleukodystrophy |
| Founded | 1993 |
| Employees | 201-500 |
| Socials |
bluebird bio Email Formats
bluebird bio uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@bluebirdbio.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@bluebirdbio.com | 45.6% |
{first initial}{last name} | jdoe@bluebirdbio.com | 26.4% |
{first name}{last name} | johndoe@bluebirdbio.com | 19.8% |
{first initial}.{last name} | j.doe@bluebirdbio.com | 3.8% |
{last name}{last name} | doedoe@bluebirdbio.com | 3.8% |
About bluebird bio
bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward. Founded in 2010, bluebird has the largest and deepest ex-vivo gene therapy data set in the world—setting the standard for the industry. Today, bluebird continues to forge new paths, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds. Community guidelines: http://bit.ly/bbbGuidelines
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
bluebird bio has 131 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore bluebird bio's funding history, including investment rounds, total capital raised, and key backers.
bluebird bio Tech Stack
Discover the technologies and tools that power bluebird bio's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript frameworks
Cookie compliance
JavaScript libraries
Analytics
JavaScript libraries
JavaScript libraries
Webmail
Security
Advertising
United Kingdom
Italy
Netherlands
Frequently asked questions
4.8
40,000 users
